Ambu rises as FDA issues import alerts on rival devices

Ambu A/S

25/06/2025 09:51

Corrects Nordea analyst name in 5 bullet point

** Shares in Ambu AMBUb.CO rise around 4% and are among top movers on Europe-wide STOXX 600 .STOXX index

** Analysts point to import alerts released by the U.S. Food and Drug Association (FDA) on some products of its Japanese competitor Olympus 7733.T

** "The affected devices include ureteroscopes and bronchoscopes (among others), where Olympus is competing with Ambu," Tobias Berg Nissen, Danske Bank analyst on healthcare, says

** Nissen notes this could provide some tailwind for the Danish endoscope maker as hospitals seek alternatives to Olympus devices

** The alert includes the BF-P190 broncho, which is one of the most widely used Olympus bronchovideoscopes, and that might slightly improve Ambu sales near term, Martin Brenoe from Nordea notes

** Olympus shares close down 10.6% on Wednesday in Tokyo trading

 (Reporting by Vera Dvorakova, Boleslaw Lasocki)

 ((vera.dvorakova@thomsonreuters.com))